Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selumetinib and Sirolimus in MPNST
NCT03433183Phase 2Completed
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Start
- Oct 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selumetinib, sirolimus in malignant peripheral nerve sheath tumor (MPNST), sponsored by Sarcoma Alliance for Research through Collaboration. Started Oct 2019; status: completed.
02
Drugs
selumetinibsirolimus
03
Conditions
malignant peripheral nerve sheath tumor (MPNST)
Beyond the preview
Go deeper on NCT03433183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03433183.